# AIM ImmunoTech Inc.: Form 8-K, filed Sep 12, 2024

- Company: [AIM ImmunoTech Inc.](/companies/aim.md) (CIK 946644)
- Form: 8-K
- Filed: 2024-09-12
- Accepted by EDGAR: Sep 12, 2024, 16:45 ET
- Period: 2024-09-11
- Accession: 0001493152-24-036060
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/form8-k.htm

Filed Sep 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-036060. Last ingested by Listed: Nov 14, 2026, 11:22 ET. No prices; not investment advice.
